why choose us

First received: October 15, 2024

Clinical Trial: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: IgA Nephropathy (IgAN)

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, and Placebo-controlled Parallel Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK39297 Tablets in Treatment of Patients With Primary IgAN

Brief Summary: Evaluate the efficacy and safety of HSK39297 tablets in patients with primary IgAN

Read more